» Articles » PMID: 38203570

Effect of Mycolic Acids on Host Immunity and Lipid Metabolism

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Jan 11
PMID 38203570
Authors
Affiliations
Soon will be listed here.
Abstract

Mycolic acids constitute pivotal constituents within the cell wall structure of . Due to their structural diversity, the composition of mycolic acids exhibits substantial variations among different strains, endowing them with the distinctive label of being the 'signature' feature of mycobacterial species. Within , the primary classes of mycolic acids include α-, keto-, and methoxy-mycolic acids. While these mycolic acids are predominantly esterified to the cell wall components (such as arabinogalactan, alginate, or glucose) of , a fraction of free mycolic acids are secreted during in vitro growth of the bacterium. Remarkably, different types of mycolic acids possess varying capabilities to induce foamy macro-phages and trigger immune responses. Additionally, mycolic acids play a regulatory role in the lipid metabolism of host cells, thereby exerting influence over the progression of tuberculosis. Consequently, the multifaceted properties of mycolic acids shape the immune evasion strategy employed by . A comprehensive understanding of mycolic acids is of paramount significance in the pursuit of developing tuberculosis therapeutics and unraveling the intricacies of its pathogenic mechanisms.

Citing Articles

Advances in Host-Pathogen Interactions in Tuberculosis: Emerging Strategies for Therapeutic Intervention.

Nasiri M, Venketaraman V Int J Mol Sci. 2025; 26(4).

PMID: 40004082 PMC: 11855387. DOI: 10.3390/ijms26041621.


Mycobacterium tuberculosis: The Mechanism of Pathogenicity, Immune Responses, and Diagnostic Challenges.

Mohammadnabi N, Shamseddin J, Emadi M, Bodaghi A, Varseh M, Shariati A J Clin Lab Anal. 2024; 38(23):e25122.

PMID: 39593272 PMC: 11632860. DOI: 10.1002/jcla.25122.

References
1.
Flynn J, GOLDSTEIN M, Triebold K, Sypek J, Wolf S, Bloom B . IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol. 1995; 155(5):2515-24. View

2.
Agger E, Rosenkrands I, Hansen J, Brahimi K, Vandahl B, Aagaard C . Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements. PLoS One. 2008; 3(9):e3116. PMC: 2525815. DOI: 10.1371/journal.pone.0003116. View

3.
Iizasa E, Chuma Y, Uematsu T, Kubota M, Kawaguchi H, Umemura M . TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation. Nat Commun. 2021; 12(1):2299. PMC: 8052348. DOI: 10.1038/s41467-021-22620-3. View

4.
Dabla A, Liang Y, Rajabalee N, Irwin C, Moonen C, Willis J . TREM2 Promotes Immune Evasion by Mycobacterium tuberculosis in Human Macrophages. mBio. 2022; 13(4):e0145622. PMC: 9426521. DOI: 10.1128/mbio.01456-22. View

5.
Pieters J . Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe. 2008; 3(6):399-407. DOI: 10.1016/j.chom.2008.05.006. View